Investment Thesis
PFHO demonstrates exceptional profitability with a 20.7% net margin and fortress balance sheet (zero debt, 34.45x current ratio), but net income stagnated YoY despite 10.7% revenue growth, signaling margin compression or operational challenges. The micro-cap scale ($6.7M revenue) and OTC listing limit growth potential and liquidity.
Strengths
- Exceptional net profit margin of 20.7% for health care services sector
- Fortress balance sheet with zero debt, minimal liabilities, and extraordinary liquidity
- Positive free cash flow generation with 16.9% FCF margin and healthy ROA/ROE above 10%
Risks
- Net income growth of 0% YoY despite 10.7% revenue growth indicates margin compression or operational inefficiency
- Micro-cap company with only $6.7M revenue limits scalability and growth runway
- OTC listing creates liquidity constraints and minimal institutional investor coverage
Key Metrics to Watch
- Net income and operating margin trends relative to revenue growth
- Revenue growth sustainability and gross margin visibility
- Capital allocation efficiency and return on equity trends
Financial Metrics
Revenue
6.7M
Net Income
1.4M
EPS (Diluted)
$0.11
Free Cash Flow
1.1M
Total Assets
13.5M
Cash
2.2M
Profitability Ratios
Gross Margin
N/A
Operating Margin
14.9%
Net Margin
20.7%
ROE
10.6%
ROA
10.3%
FCF Margin
16.9%
Balance Sheet & Liquidity
Current Ratio
34.45x
Quick Ratio
34.45x
Debt/Equity
0.00x
Debt/Assets
5.5%
Interest Coverage
657.71x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-14T05:48:24.267809 |
Data as of: 2025-12-31 |
Powered by Claude AI